Mechanical Circulatory Support : A Potential Mechanism for Cardiac Recovery in Failing Human Myocardium After α Decreased Expression of Tumor Necrosis Factor

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts.

  2000cited by this paper
• THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE

  2000cited by this paper
• Safety and Efficacy of a Soluble P 75 Tumor Necrosis Factor Receptor ( Enbrel , Etanercept ) in Patients With Advanced Heart Failure

  1999cited by this paper
• Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

  1999cited by this paper
• Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α

  1998cited by this paper
• Regression of cellular hypertrophy after left ventricular assist device support.

  1998cited by this paper
• Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.

  1998cited by this paper
• Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha.

  1997cited by this paper
• Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium.

  1997cited by this paper
• Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy.

  1997cited by this paper
• Improved left ventricular function after chronic left ventricular unloading.

  1996cited by this paper
• Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

  1996cited by this paper
• Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts.

  1996cited by this paper
• Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart

  1996cited by this paper
• Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy.

  1995cited by this paper
• Structural and left ventricular histologic changes after implantable LVAD insertion.

  1995cited by this paper
• Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines.

  1994cited by this paper
• Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism.

  1993cited by this paper
• ACE inhibitors--a cornerstone of the treatment of heart failure.

  1991cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990cited by this paper

• Olive oil protects against progression of heart failure by inhibiting remodeling of heart subsequent to myocardial infarction in rats

  2022cites this paper
• Importance of Tumor Necrosis Factor-Alpha in the Pathogenesis of Heart Failure

  2022cites this paper
• Biology of myocardial recovery in advanced heart failure with long-term mechanical support.

  2022cites this paper
• A Peek at LVADs Pumping to Recovery

  2022cites this paper
• Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure

  2022cites this paper
• Biomarkers in the clinical management of patients with atrial fibrillation and heart failure

  2021cites this paper
• Наиболее часто встречающиеся сопутствующие заболевания сердечно-сосудистой системы и методы их периоперационной оценки у кандидатов на трансплантацию печени

  2020cites this paper
• Alterations of the renin angiotensin system in human end-stage heart failure before and after mechanical cardiac unloading by LVAD support

  2020cites this paper
• Reappraising the role of inflammation in heart failure

  2020cites this paper
• Common cardiac comorbidities and perioperative assessment modalities for liver transplant candidates – an update

  2020cites this paper
• The Biological Response to Ventricular Unloading

  2020cites this paper
• Cardiac Remodeling: The Course Towards Heart Failure-II. Diagnostic and Therapeutic Approaches

  2019cites this paper
• Improved 6 Minute Walk Distance and Brain-Type Natriuretic Peptide After Continuous-Flow Ventricular Assist Device Placement in Children.

  2019cites this paper
• Physiological aspects of myocardial function improving during mechanical circulatory support

  2019cites this paper
• Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices.

  2018cites this paper
• Alcohol-Mediated Organ Damages: Heart and Brain

  2018cites this paper
• Restoration Of Left Ventricular Function Following LVAD Implantation – Remission Or Recovery? A Case series

  2018cites this paper
• Recovery of failing hearts by mechanical unloading: Pathophysiologic insights and clinical relevance

  2018cites this paper
• Technology & Medicine Open Access book

  2017cites this paper
• Heterotopic Abdominal Rat Heart Transplantation as a Model to Investigate Volume Dependency of Myocardial Remodeling

  2017cites this paper
• Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).

  2016cites this paper
• Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure

  2016cites this paper
• Transcriptional patterns of reverse remodeling with left ventricular assist devices: a consistent signature

  2016cites this paper
• New therapy, new challenges: The effects of long-term continuous flow left ventricular assist device on inflammation.

  2016cites this paper
• Advances in temporary mechanical support for treatment of cardiogenic shock

  2015cites this paper
• The war against heart failure: the Lancet lecture.

  2015cites this paper
• Association between serum total antioxidant status and coronary microvascular function in idiopathic dilated cardiomyopathy

  2015cites this paper
• Surgical Treatment of Advanced Heart Failure

  2015cites this paper
• Myocardial interleukin-6 in the setting of left ventricular mechanical assistance: relation with outcome and C-reactive protein

  2015cites this paper
• Heart failure in remission for more than 13 years after removal of a left ventricular assist device.

  2014cites this paper
• Mechanical circulatory support improves diabetic control in patients with advanced heart failure

  2014cites this paper
• Molecular and Cellular Basis of Viable Dysfunctional Myocardium

  2014cites this paper
• Myocardial recovery and the failing heart: medical, device and mechanical methods.

  2014cites this paper
• Heart Failure in Remission for More than 13 Years

  2014cites this paper
• Cellular, molecular, genomic changes occurring in the heart under mechanical circulatory support.

  2014cites this paper
• Left and Right Ventricular Remodeling

  2014cites this paper
• Contribution of ventricular assist devices to the recovery of failing hearts: a review and the Berlin Heart Center Experience

  2014cites this paper
• Improvement in Blood Glucose Control in Patients With Diabetes After Implantation of Left Ventricular Assist Devices

  2014cites this paper
• Identification of Differentially Expressed Transcripts and Pathways in Blood One Week and Six Months Following Implant of Left Ventricular Assist Devices

  2013cites this paper
• Molecular changes after left ventricular assist device support for heart failure.

  2013cites this paper
• Protective role of olive oil and its major component oleic acid in TNF-α induced remodeling subsequent to myocardial infarction in rats

  2013influential citation
• Treatment of cachexia: melanocortin and ghrelin interventions.

  2013cites this paper
• Increased low-grade inflammation is associated with lack of functional response to carvedilol in patients with systolic heart failure

  2013cites this paper
• Development of a physiologic ex vivo vessel perfusion system.

  2013cites this paper
• Left ventricular remodeling: one small step for the extracellular matrix will translate to a giant leap for the myocardium.

  2013cites this paper
• Heart failure.

  2013cites this paper
• Increased Levels of Retinol Binding Protein 4 in Patients With Advanced Heart Failure Correct After Hemodynamic Improvement Through Ventricular Assist Device Placement

  2012cites this paper
• Differential expression of caveolin-1 and caveolin-3: potential marker for cardiac toxicity subsequent to chronic ozone inhalation

  2012cites this paper
• Advances in Mechanical Circulatory Support Bridge to Recovery Understanding the Disconnect Between Clinical and Biological Outcomes

  2012cites this paper
• Role of Tumour Necrosis Factor-α in the Progression of Heart Failure

  2012cites this paper
• Myocardial reverse remodeling.

  2012cites this paper
• Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy.

  2012cites this paper
• Severity of oxidative stress and inflammatory activation in end-stage heart failure patients are unaltered after 1 month of left ventricular mechanical assistance.

  2012cites this paper
• Control Strategies for Afterload Reduction With an Artificial Vasculature Device

  2012cites this paper
• The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly

  2012cites this paper
• State‐of‐the‐Art Implantable Cardiac Assist Device Therapy for Heart Failure: Bridge to Transplant and Destination Therapy

  2012cites this paper
• Myocardial Recovery With Left Ventricular Assist Devices

  2012cites this paper
• Cellular, Molecular, Genomic, and Functional Changes That Occur in the Failing Heart in Response to Mechanical Circulatory Support

  2012cites this paper
• Options for Advanced Mechanical Support for Cardiogenic Shock Complicating Cardiac Reoperations

  2012cites this paper
• Reverse remodeling and recovery from cachexia in rats with aldosteronism.

  2012cites this paper
• Increased levels of retinol binding protein 4 in patients with advanced heart failure correct after hemodynamic improvement through ventricular assist device placement.

  2011cites this paper
• Advances in Heart Failure Reverse Remodeling With Left Ventricular Assist Devices

  2011cites this paper
• Follistatin-Like 1 in Chronic Systolic Heart Failure: A Marker of Left Ventricular Remodeling

  2011cites this paper
• Reverse Remodeling With Left Ventricular Assist Devices: A Review of Clinical, Cellular, and Molecular Effects

  2011cites this paper
• Chronotropic Incompetence and Abnormal Heart Rate Recovery Early after Left Ventricular Assist Device Implantation

  2011cites this paper
• Flow Modulation Algorithms for Continuous Flow Left Ventricular Assist Devices to Increase Vascular Pulsatility: A Computer Simulation Study

  2011cites this paper
• Feasibility of cell transplantation with a left ventricular assist device to improve the success rate of left ventricular assist device removal: the first experiment.

  2011cites this paper
• End Stage Heart Failure – Transplantation or Lvad ?

  2011cites this paper
• Myocardial Recovery Following Left Ventricular Assist Device Therapy

  2011cites this paper
• Chapter 56 – Circulatory Assist Devices in Heart Failure

  2011cites this paper
• Cellular evidence of reverse cardiac remodeling induced by cardiac resynchronization therapy.

  2011cites this paper
• Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading.

  2010cites this paper
• Myocardial Proteases and Matrix Remodeling in Acute Myocarditis and Inflammatory Cardiomyopathy

  2010cites this paper
• beta-adrenergic pathway properties Left ventricular assist device support normalizes left and right ventricular

  2010cites this paper
• Ventricular Assist Devices and Total Artificial Hearts

  2010cites this paper
• Biomarkers of inflammation in heart failure

  2010cites this paper
• Inflammatory cardiomyopathy (DCMi) : pathogenesis and therapy

  2010cites this paper
• Short-term mechanical unloading and reverse remodeling of failing hearts in children.

  2010cites this paper
• CHAPTER 47 – Ventricular Assist Device Therapy in Advanced Heart Failure—State of the Art

  2010cites this paper
• Left ventricular remodeling and myocardial recovery on mechanical circulatory support.

  2010cites this paper
• Reciprocal Regulation of Myocardial microRNAs and Messenger RNA in Human Cardiomyopathy and Reversal of the microRNA Signature by Biomechanical Support

  2009cites this paper
• Inflammatory in Hear t Failure Revisited: Much More than Innocent Bystanders

  2009cites this paper
• Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.

  2009cites this paper
• Ventricular assist device therapy.

  2009cites this paper
• Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders.

  2009cites this paper
• Significance of anaemia in patients with advanced heart failure receiving long‐term mechanical circulatory support

  2009cites this paper
• Mechanical unloading and β2-adrenoceptor stimulation for the treatment of heart failure.

  2009cites this paper
• Cytokines and acute heart failure

  2008cites this paper
• Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group

  2008cites this paper
• Morphological and Molecular Changes of the Myocardium After Left Ventricular Mechanical Support

  2008cites this paper
• Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.

  2008cites this paper
• Cardiac recovery during mechanical assist device support.

  2008cites this paper
• Myocardial Fas and Cytokine Expression in End‐Stage Heart Failure: Impact of LVAD Support

  2008cites this paper
• Left ventricular assist device-induced molecular changes in the failing myocardium

  2008cites this paper
• [Left ventricular assist device - unexpected benefits for the failing heart].

  2008cites this paper
• Biology of TNFα and IL-10, and their imbalance in heart failure

  2008cites this paper
• Current and future considerations in the use of mechanical circulatory support devices.

  2008cites this paper
• Interleukin‐10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction

  2008influential citation
• Cardiac Improvement During Mechanical Circulatory Support

  2007cites this paper
• Ventricular-assist devices for the treatment of chronic heart failure

  2007cites this paper